Diabetes
Team reports progress in developing specific immunotherapies for type 1 diabetes
Researchers from Germans Trias i Pujol Research Institute (IGTP) and Ahead Therapeutics SL have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 diabetes for years. A study ...
14 hours ago
0
1